New Insights into Cardiovascular Immunology

A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Medicine".

Deadline for manuscript submissions: 15 June 2025 | Viewed by 2901

Special Issue Editors


E-Mail Website
Guest Editor
National Heart and Lung Institute, Imperial College London, London, UK
Interests: myocardial infarction; heart failure; autoimmunity; adaptive immune system; autoantibodies

E-Mail Website
Guest Editor
Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Sapin
Interests: autoimmunity; myocarditis; heart failure; microRNAs

E-Mail Website
Guest Editor
Department of Medicine, The Karolinska Institute, Stockholm, Sweden
Interests: atherosclerosis; Immune system; lipoproteins

Special Issue Information

Dear Colleagues,

Cardiovascular immunology is a young but rapidly expanding field of research. While inflammation has been understood to be a critical aspect of atherosclerosis for some time, cardiology has only recently realized the critical importance of the immune system to the heart itself. They are entwined in a bidirectional crosstalk, and the border between immunology and cardiology is becoming increasingly blurry. This has sparked new and exciting research endeavours, and significant hope that the first immunomodulatory treatment for cardiology patients will soon see the light of day.

In this Special Issue, we invite contributions on all topics related to cardiovascular immunology that are relevant to the heart. These may include clinical and experimental research on the immunology of cardiac conditions, including ischaemic, infectious and inflammatory/autoimmune heart disease and the role of the immune system in heart failure.

In this Special Issue, we also aim to shine a light on the exciting research happening across the world, and we particularly encourage researchers from underrepresented groups and areas to submit their work.

Dr. Susanne Sattler
Dr. Pilar Martín
Dr. Stephen Malin
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • inflammation
  • autoimmunity
  • atherosclerosis
  • myocarditis
  • heart failure

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

13 pages, 707 KiB  
Review
Emerging Roles for Dendritic Cells in Heart Failure
by Danish Saleh, Rebecca T. L. Jones, Samantha L. Schroth, Edward B. Thorp and Matthew J. Feinstein
Biomolecules 2023, 13(10), 1535; https://doi.org/10.3390/biom13101535 - 17 Oct 2023
Cited by 3 | Viewed by 2346
Abstract
The field of cardio-immunology has emerged from discoveries that define roles for innate and adaptive immune responses associated with myocardial inflammation and heart failure. Dendritic cells (DCs) comprise an important cellular compartment that contributes to systemic immune surveillance at the junction of innate [...] Read more.
The field of cardio-immunology has emerged from discoveries that define roles for innate and adaptive immune responses associated with myocardial inflammation and heart failure. Dendritic cells (DCs) comprise an important cellular compartment that contributes to systemic immune surveillance at the junction of innate and adaptive immunity. Once described as a singular immune subset, we now appreciate that DCs consist of a heterogeneous pool of subpopulations, each with distinct effector functions that can uniquely regulate the acute and chronic inflammatory response. Nevertheless, the cardiovascular-specific context involving DCs in negotiating the biological response to myocardial injury is not well understood. Herein, we review our current understanding of the role of DCs in cardiac inflammation and heart failure, including gaps in knowledge and clinical relevance. Full article
(This article belongs to the Special Issue New Insights into Cardiovascular Immunology)
Show Figures

Figure 1

Back to TopTop